Dwimantoro Iman Prilistiyo, A Santoso, L Anniwati, W J Pudjirahardjo

Abstract views = 460 times | downloads = 419 times


Urosepsis occurs in 20-30 % of septic case. Early diagnosis were undoubtfully important to improve the results of sepsis management. Bacteriological confirmation may be difficult to obtain and negative cultures do not exclude the presence of infection. Increased understanding of inflammatory cascade mechanisms provided several indicator of infection and prognosis. Lactate measurement in patients with infection and possibly severe sepsis to help identify patients at high risk of death in order to apply aggressively therapy. Elevation in serum C-reactive protein (CRP) is also associated with an increasing risk of death in patients with infection. This study was to determine the plasma lactate and CRP levels of patients with urosepsis as a prognostic indicator. This is an analytic observational study to compare the correlation and significance of plasma lactate and CRP with prognosis of urosepsis. Each subject was measured for plasma lactate and serum CRP at time of admission. All subjects were managed according to standard protocol. At the 14th day of treatment, patients were evaluated with a clinical severity score. The outcome was classified as follows: 1=good condition/improved, 2=morbid/worsened and 3=death. The statistical analysis used Spearman’s rho test, ρ<0.05 was considerated to indicate significance. We enrolled 25 subjects with urosepsis. 14 patients who were septic, nine patients had severe sepsis and 2 patients had septic shock. Mean plasma lactate level in patients based on outcome (improved/worsened/death) was 2.08 mmol/L; 4.16 mmol/L and 5.27 mmol/L. The mean value of CRP was 13.41 mg/L; 22.28 mg/L and 24.62 mg/L. These were statistically significant (p 0.008 vs 0.016) in determining the outcome of the urosepsis patient. The coefficient correlation is better with plasma lactate than CRP (0.517 vs 0.475). In conclusion, the measurement of plasma lactate and CRP level can be used as a prognostic marker for the outcome of patient with urosepsis. Plasma lactate showed higher correlation with outcome of urosepsis than CRP.


Plasma lactate; CRP; Urosepsis

Full Text:



Bakker J, Maarten WN, Jansen T (2013). Clinical use lactate minitoring in critically ill patients. Annals of Intensive Care Vol 3, 12

Bochud C (2003). Science, medicine and the future: pathogenesis of sepsis: new concepts and implications for future treatment. BMJ Vol 326, 262-6

Bone RC, Balk R, Cerra FB, et al (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in Sepsis. J Chest Vol 101, 1644-55

Gladden (2004). Lactate metabolism: A new paradigm for the third millennium. Journal of Physiology Vol 558, 5-30

Kalra OP and Raizada A (2009). Approach to patient with urosepsis. Journal of Global Infectious Disease Vol 1, 57-63

Lever A, Mackenzie I (2007). Sepsis: definition, epidemiology, and diagnosis. BMJ Vol 335(7625), 879-83

Marx G, Reinhart K (2008). Urosepsis: from the intensive care viewpoint. Int J Antimicrob Agents Vol 1, S79-84

Schaeffer AJ, Schaeffer E (2010). Infections of the urinary tract Cambell-Walsh Urology, Ch 8; 10th Ed, 287-9

Schiefer HG, Diemer TH (2007). Urosepsis; Emergencies in urology. Springer – Verlag. Ch 5, 45-9

Schuetz P, Crain MC, Muller B (2008). Procalcitonin and other biomarkers for the assessment of disease severity and guidance of treatment in bacterial infections. Advances in Sepsis Vol 6, 82-9

Shapiro, Howell MD (2005). Serum Lactate as Predictor of Mortality in Emergency Dept. patients with Infection. Ann Emerg Med. 45:524-8

Suzana MA, Francisco RM, Daliana PB, et al. (2003). C-reactive protein levels correlate with mortality and organ failure in critically ill patients. American Collage of Chest Physicians Vol 123, 2043-2049

Vincent JL, Beumier M (2013). Diagnostic and prognostic markers in sepsis. Expert Rev Anti Infect Ther. Mar Vol 11(3), 265-75

Von Landenberg P, Shoenfeld Y (2001). New approaches in the diagnosis of sepsis. Isr Med Assoc J. Jun Vol 3(6), 439-42

Wagenlehner FM, Pilatz A, Naber KG, et al (2008). Therapeutic challenges of urosepsis. Eur J Clin Invest. Oct 38 Suppl 2, 45-9


  • There are currently no refbacks.

Copyright (c) 2017 Folia Medica Indonesiana

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




View My Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License